Envoy Medical (NASDAQ:COCH) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.30) by 13.33 percent. This is a 43.48 percent increase over losses of $(0.46) per share from the same period last year. The company reported quarterly sales of $75.000 thousand which beat the analyst consensus estimate of $70.000 thousand by 7.14 percent. This is a 78.57 percent increase over sales of $42.000 thousand the same period last year.